Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

NCR Atleos (NATL) Research & Development (2022 - 2025)

Historic Research & Development for NCR Atleos (NATL) over the last 4 years, with Q3 2025 value amounting to $18.0 million.

  • NCR Atleos' Research & Development rose 2000.0% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.0 million, marking a year-over-year increase of 289.86%. This contributed to the annual value of $62.0 million for FY2024, which is 2250.0% down from last year.
  • Latest data reveals that NCR Atleos reported Research & Development of $18.0 million as of Q3 2025, which was up 2000.0% from $17.0 million recorded in Q2 2025.
  • NCR Atleos' Research & Development's 5-year high stood at $26.0 million during Q4 2023, with a 5-year trough of $7.0 million in Q3 2022.
  • For the 4-year period, NCR Atleos' Research & Development averaged around $17.0 million, with its median value being $17.0 million (2023).
  • Its Research & Development has fluctuated over the past 5 years, first surged by 14285.71% in 2023, then tumbled by 4210.53% in 2024.
  • Over the past 4 years, NCR Atleos' Research & Development (Quarter) stood at $12.0 million in 2022, then soared by 116.67% to $26.0 million in 2023, then decreased by 26.92% to $19.0 million in 2024, then dropped by 5.26% to $18.0 million in 2025.
  • Its last three reported values are $18.0 million in Q3 2025, $17.0 million for Q2 2025, and $17.0 million during Q1 2025.